alexa Interview | Mojtaba AkhtarinbspChemotherapy Open Access
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Mojtaba Akhtari
Mojtaba Akhtari

Executive Editor
Mojtaba Akhtari
Division of Hematology and Oncology
University of Nebraska Medical Center
Omaha, USA
Tel. 402-559-3834
Fax. 402-559-6520
Read Interview session with Mojtaba Akhtari

 
Biography

Dr. Mojtaba Akhtari is an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Nebraska Medical Center. He earned his medical degree from Tehran University of Medical Sciences in Tehran, Iran. Then, he moved to England, where he received training in internal medicine and hematology. He served in the Department of Hematological Medicine, King’s College Hospital in London, England. He moved to Evanston, Illinois, USA, where he completed his residency in internal medicine at Saint Francis Hospital of Evanston, and he also received Humanism in Medicine Award. He undertook fellowship training in hematology and medical oncology at Winship Cancer Institute, Emory University School of Medicine in Atlanta, Georgia, and during this time he specialized in the management of benign and malignant hematological disorders, stem cell transplantation, and solid tumors. He is board certified in Internal medicine, Hematology and Medical Oncology. He is an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO) and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN).

 
Research Interest

Acute and chronic leukemias as well as myelodysplastic syndromes, therapy-related myeloid neoplasms, familial leukemias, immune cytopenias, and bone marrow transplantation.

Interview
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7